Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gisselbrecht

Showing results (11-20 of 215) with videos related to

Pageof 22
Sort By:
La Revue Du Praticien|September 1, 1993
[Aggressive lymphomas]C Gisselbrecht
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Chemotherapy dose intensity facilitated by use of lenograstim--implications for quality of life and survivalC Gisselbrecht
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Myelodysplasia after autotransplantationN Mounier, C Gisselbrecht
Bulletin Du Cancer|October 18, 2001
[Therapy intensification with autologous transplantation in non-Hodgkin's lymphomas]A Bosly, C Gisselbrecht
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphomaN Mounier, C Gisselbrecht
Nouvelle Revue Francaise D'Hematologie|February 1, 1993
Mycosis fungoides and the Sézary syndromeC Gisselbrecht, L Dubertret
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2006
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL studyH Hagberg, C Gisselbrecht,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2006
Managing large cell lymphomaC Gisselbrecht, N Mounier
Leukemia & Lymphoma|January 1, 1995
Prognostic factors in advanced Hodgkin's disease: problems and pitfalls. Towards an international prognostic indexC Gisselbrecht, C Ferme
La Revue Du Praticien|February 1, 1994
[Superficial adenopathy. Diagnostic orientation]P Brice, C Gisselbrecht
Pageof 22

Showing results (11-20 of 215) with videos related to

Sort By:
Pageof 22
La Revue Du Praticien|September 1, 1993
[Aggressive lymphomas]C Gisselbrecht
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Chemotherapy dose intensity facilitated by use of lenograstim--implications for quality of life and survivalC Gisselbrecht
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Myelodysplasia after autotransplantationN Mounier, C Gisselbrecht
Bulletin Du Cancer|October 18, 2001
[Therapy intensification with autologous transplantation in non-Hodgkin's lymphomas]A Bosly, C Gisselbrecht
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphomaN Mounier, C Gisselbrecht
Nouvelle Revue Francaise D'Hematologie|February 1, 1993
Mycosis fungoides and the Sézary syndromeC Gisselbrecht, L Dubertret
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2006
Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL studyH Hagberg, C Gisselbrecht,
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2006
Managing large cell lymphomaC Gisselbrecht, N Mounier
Leukemia & Lymphoma|January 1, 1995
Prognostic factors in advanced Hodgkin's disease: problems and pitfalls. Towards an international prognostic indexC Gisselbrecht, C Ferme
La Revue Du Praticien|February 1, 1994
[Superficial adenopathy. Diagnostic orientation]P Brice, C Gisselbrecht
Pageof 22